Skip to main content
IRESSA 250 mg/1 tablet, coated by AstraZeneca Pharmaceuticals LP
IRESSA, 250 mg/1, tablet, coated Drug class: Kinase Inhibitor. Available on prescription only. Listed by AstraZeneca Pharmaceuticals LP.
Prescription only

IRESSA

Gefitinib

Listed by AstraZeneca Pharmaceuticals LP

Strength
250 mg/1
Form
Tablet, Coated
Route
Oral
Class
Kinase Inhibitor

What it contains

  • Gefitinib 250 mg/1

FDA record

Dosage form Tablet, Coated
Route Oral
Drug class Kinase Inhibitor
Approval route NDA — original brand approval
NDC code 0310-0482
FDA application NDA206995
RxNorm concept 349472
Package sizes listed 1
Marketed since July 2015

Other products containing Gefitinib

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Gefitinib

Strength
250 mg/1
Form
Tablet, Coated
Class
Kinase Inhibitor
Rx only Generic

Ingenus Pharmaceuticals, LLC

$189.00 We supply Geftinat 250 mg (1 pack / 30 tabs) View product

Gefitinib

Strength
250 mg/1
Form
Tablet, Coated
Class
Kinase Inhibitor
Rx only Generic

Qilu Pharmaceutical Co., Ltd.

$189.00 We supply Geftinat 250 mg (1 pack / 30 tabs) View product

Gefitinib

Strength
250 mg/1
Form
Tablet, Film Coated
Class
Kinase Inhibitor
Rx only Generic

Natco Pharma USA LLC

$189.00 We supply Geftinat 250 mg (1 pack / 30 tabs) View product

Gefitinib

Strength
250 mg/1
Form
Tablet, Film Coated
Class
Kinase Inhibitor
Rx only Generic

Teva Pharmaceuticals, Inc.

$189.00 We supply Geftinat 250 mg (1 pack / 30 tabs) View product

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.